APA

Dodick D. W., Turkel C. C., DeGryse R. E., Aurora S. K., Silberstein S. D., Lipton R. B., Diener H. & Brin M. F. (20101008). OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. : Headache.

Chicago

Dodick David W, Turkel Catherine C, DeGryse Ronald E, Aurora Sheena K, Silberstein Stephen D, Lipton Richard B, Diener Hans-Christoph and Brin Mitchell F. 20101008. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. : Headache.

Harvard

Dodick D. W., Turkel C. C., DeGryse R. E., Aurora S. K., Silberstein S. D., Lipton R. B., Diener H. and Brin M. F. (20101008). OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. : Headache.

MLA

Dodick David W, Turkel Catherine C, DeGryse Ronald E, Aurora Sheena K, Silberstein Stephen D, Lipton Richard B, Diener Hans-Christoph and Brin Mitchell F. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. : Headache. 20101008.